Immutep (IMMP) vs Shuttle Pharmaceuticals (SHPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immutep (IMMP) has outperformed Shuttle Pharmaceuticals (SHPH) over the past year, gaining 90.1% versus a loss of 87.4%. Immutep is the larger company by market cap ($28.3 million vs $26.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMMP | SHPH |
|---|---|---|
| Share price | $3.84 | $5.55 |
| Market cap | $28.30M | $26.44M |
| 1-day change | -6.56% | +17.83% |
| YTD return | +34.27% | -69.17% |
| 1-year return | +90.10% | -87.36% |
| 5-year return | +2.78% | — |
| EPS (TTM) | $-7.30 | $-16.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $70.60 | $55.90 |
| 52-week low | $3.80 | $2.58 |
| Distance from 52-week high | -94.56% | -90.07% |
| Average volume | 14.70K | 1.36M |
| Shares outstanding | 7.37M | 4.76M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMMP has outperformed SHPH by 177.5 percentage points over the past year.
IMMP vs SHPH FAQ
Which is bigger, Immutep or Shuttle Pharmaceuticals?
Immutep (IMMP) is larger, with a market capitalization of $28.30M compared with $26.44M for Shuttle Pharmaceuticals (SHPH).
Which stock has performed better over the past year, IMMP or SHPH?
IMMP returned +90.10% over the past 12 months, compared with -87.36% for SHPH (price return, excluding dividends). Past performance does not predict future results.
Are Immutep and Shuttle Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.